acetyl dipeptide-1
Neurotransmitter inhibitor dipeptide that stimulates nerve cells to release met-enkephalin, an endogenous opioid peptide. Results in muscle relaxation and reduced skin inflammation. Mechanism is distinct from SNARE complex inhibitors and postsynaptic receptor antagonists, enabling multi-pathway combination formulation strategies.
Limited Data
Insufficient safety data available. Consider enriching this ingredient.
Details
Description
Neurotransmitter inhibitor dipeptide that stimulates nerve cells to release met-enkephalin, an endogenous opioid peptide. Results in muscle relaxation and reduced skin inflammation. Mechanism is distinct from SNARE complex inhibitors and postsynaptic receptor antagonists, enabling multi-pathway combination formulation strategies.
Purpose
Function
Neurotransmitter inhibitor dipeptide that stimulates nerve cells to release met-enkephalin, an endogenous opioid peptide. Results in muscle relaxation and reduced skin inflammation. Mechanism is distinct from SNARE complex inhibitors and postsynaptic receptor antagonists, enabling multi-pathway combination formulation strategies.
Profile
Properties
Silicone
Silicone free
Compliance
Regulatory Status
EU
Permitted
Safety
GOOD
US
Permitted
Absorptionnegligible
Sensitizationnone
MoSadequate
ConcernLow
Verdict
Acetyl dipeptide-1 cetyl ester is a neurocosmetic active that modulates neuropeptide signaling to reduce sensory neuron firing, addressing reactive skin symptoms through CGRP and substance P pathway modulation without EU or US restrictions.
US Note
Permitted; no US concentration cap. Used in neurocosmetic formulations targeting reactive skin.
Assessment
Ratings
Reference
Identifiers
No registry identifiers available for this ingredient.